Reynald Castaneda - Journalist Profile | Connect with top journalists

Beats

Biography

Content

Total articles 268

• Available on paid plans

  Sanofi is in the market for M&A, thanks to ‘strong’ balance sheet

  By Reynald Castaneda Verified

  Jan. 30, 2025

• Available on paid plans

  Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

  By Reynald Castaneda Verified

  Nov. 21, 2024

• Available on paid plans

  Sanofi is in the market for M&A, thanks to ‘strong’ balance sheet

  By Reynald Castaneda Verified

  Jan. 30, 2025

As seen in

Company Info

Endpoints News

Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.